Parkwood LLC’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-50,749
| Closed | -$825K | – | 83 |
|
|
2024
Q2 | $825K | Buy |
50,749
+4,479
| +10% | +$72.8K | 0.1% | 97 |
|
|
2024
Q1 | $856K | Buy |
46,270
+23,806
| +106% | +$440K | 0.08% | 141 |
|
|
2023
Q4 | $703K | Buy |
22,464
+2,116
| +10% | +$66.2K | 0.08% | 91 |
|
|
2023
Q3 | $424K | Buy |
20,348
+1,813
| +10% | +$37.8K | 0.05% | 100 |
|
|
2023
Q2 | $444K | Buy |
18,535
+1,393
| +8% | +$33.4K | 0.08% | 107 |
|
|
2023
Q1 | $323K | Sell |
17,142
-10,174
| -37% | -$192K | 0.04% | 125 |
|
|
2022
Q4 | $435K | Buy |
27,316
+8,915
| +48% | +$142K | 0.07% | 109 |
|
|
2022
Q3 | $301K | Sell |
18,401
-6,433
| -26% | -$105K | 0.05% | 124 |
|
|
2022
Q2 | $350K | Buy |
24,834
+7,762
| +45% | +$109K | 0.06% | 121 |
|
|
2022
Q1 | $413K | Sell |
17,072
-3,976
| -19% | -$96.2K | 0.07% | 102 |
|
|
2021
Q4 | $491K | Sell |
21,048
-7,505
| -26% | -$175K | 0.08% | 92 |
|
|
2021
Q3 | $474K | Buy |
28,553
+5,136
| +22% | +$85.3K | 0.06% | 100 |
|
|
2021
Q2 | $571K | Sell |
23,417
-3,039
| -11% | -$74.1K | 0.07% | 102 |
|
|
2021
Q1 | $683K | Buy |
26,456
+988
| +4% | +$25.5K | 0.12% | 84 |
|
|
2020
Q4 | $1.36M | Buy |
+25,468
| New | +$1.36M | 0.17% | 78 |
|